Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Reactions to treatment debriefing among the participants of a placebo controlled trial.

Di Blasi Z, Crawford F, Bradley C, Kleijnen J.

BMC Health Serv Res. 2005 Apr 22;5(1):30.

2.

Informing participants of allocation to placebo at trial closure: postal survey.

Di Blasi Z, Kaptchuk TJ, Weinman J, Kleijnen J.

BMJ. 2002 Dec 7;325(7376):1329.

3.

Lay public's understanding of equipoise and randomisation in randomised controlled trials.

Robinson EJ, Kerr CE, Stevens AJ, Lilford RJ, Braunholtz DA, Edwards SJ, Beck SR, Rowley MG.

Health Technol Assess. 2005 Mar;9(8):1-192, iii-iv.

4.

Are subjects satisfied with the informed consent process? A survey of research participants.

Pope JE, Tingey DP, Arnold JM, Hong P, Ouimet JM, Krizova A.

J Rheumatol. 2003 Apr;30(4):815-24.

PMID:
12672205
5.

Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).

Brettschneider C, L├╝hmann D, Raspe H.

GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.

6.

Over-, under- and misuse of pain treatment in Germany.

Dietl M, Korczak D.

GMS Health Technol Assess. 2011 Apr 19;7:Doc03. doi: 10.3205/hta000094.

7.

Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial.

Lambert RG, Hutchings EJ, Grace MG, Jhangri GS, Conner-Spady B, Maksymowych WP.

Arthritis Rheum. 2007 Jul;56(7):2278-87.

8.

Perceived treatment, feedback, and placebo effects in double-blind RCTs: an experimental analysis.

Colagiuri B, Boakes RA.

Psychopharmacology (Berl). 2010 Feb;208(3):433-41. doi: 10.1007/s00213-009-1743-9.

PMID:
19997906
10.

Communicating clinical trial results to research participants.

Dorsey ER, Beck CA, Adams M, Chadwick G, de Blieck EA, McCallum C, Briner L, Deuel L, Clarke A, Stewart R, Shoulson I; Huntington Study Group TREND-HD Investigators..

Arch Neurol. 2008 Dec;65(12):1590-5. doi: 10.1001/archneurol.2008.503.

PMID:
19064746
11.

Sharing clinical trial results with adolescent idiopathic scoliosis patients.

Donaldson S, Khetani N, Maniatis G, Stephens D, Wright JG.

J Pediatr Orthop. 2009 Jul-Aug;29(5):467-75. doi: 10.1097/BPO.0b013e3181aa2356.

PMID:
19568019
12.

Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity.

Colagiuri B.

Clin Trials. 2010 Jun;7(3):246-55. doi: 10.1177/1740774510367916. Review.

PMID:
20421243
13.

Informed consent and participant perceptions of influenza vaccine trials in South Africa.

Moodley K, Pather M, Myer L.

J Med Ethics. 2005 Dec;31(12):727-32.

14.

Participants' experiences of being debriefed to placebo allocation in a clinical trial.

Bishop FL, Jacobson EE, Shaw J, Kaptchuk TJ.

Qual Health Res. 2012 Aug;22(8):1138-49. doi: 10.1177/1049732312448544.

15.

Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.

Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y.

Clin Ther. 2008 Nov;30(11):1988-2004. doi: 10.1016/j.clinthera.2008.11.009. Erratum in: Clin Ther. 2009 Feb;31(2):446. Clin Ther. 2009 Jul;31(7):1617.

PMID:
19108787
16.

Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.

Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S.

Headache. 2006 May;46(5):781-7.

PMID:
16643581
17.

"I assumed that one was a placebo": exploring the consent process in a sham controlled acupressure trial.

Hughes JG, Russell W, Breckons M, Richardson J, Lloyd-Williams M, Molassiotis A.

Complement Ther Med. 2014 Oct;22(5):903-8. doi: 10.1016/j.ctim.2014.07.005.

PMID:
25440382
18.

Participant experiences from chronic administration of a multivitamin versus placebo on subjective health and wellbeing: a double-blind qualitative analysis of a randomised controlled trial.

Sarris J, Cox KH, Camfield DA, Scholey A, Stough C, Fogg E, Kras M, White DJ, Sali A, Pipingas A.

Nutr J. 2012 Dec 14;11:110. doi: 10.1186/1475-2891-11-110.

19.

A randomised controlled multicentre trial of treatments for adolescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability - the TOuCAN trial.

Gowers SG, Clark AF, Roberts C, Byford S, Barrett B, Griffiths A, Edwards V, Bryan C, Smethurst N, Rowlands L, Roots P.

Health Technol Assess. 2010 Mar;14(15):1-98. doi: 10.3310/hta14150.

20.
Items per page

Supplemental Content

Support Center